According to a new report Asia Pacific Cochlear Implants Market, published by KBV Research, the Asia Pacific Cochlear Implants Market would witness market growth of 11.4% growth rate during the forecast period (2019-2025).
The China market dominated the Asia Pacific Cochlear Implants Market by Country 2018, thereby, achieving a market value of $200.7 million by 2025, growing at a CAGR of 9.1 % during the forecast period. The Japan market is expected to witness a CAGR of 12.4% during (2019 - 2025). Additionally, The India market is expected to witness a CAGR of 12.4% during (2019 - 2025).
The Unilateral Implantation market registered the highest market share in the Asia Pacific Cochlear Implants Market by Fitting Type 2018 and is expected to achieve a market value of $631 million by 2025. The Bilateral Implantation market is forecasted to experience a growth of 13.8% CAGR during (2019 - 2025).
The Adults market would attain a market size of $437.2 million by 2025, rising at a growth rate of 10.9% CAGR during the forecast period. The Pediatrics market would witness a growth of 12.2% CAGR during (2019 - 2025).
Full Report:https://www.kbvresearch.com/asia-pacific-cochlear-implants-market/
Based on Fitting Type, the market is segmented into Unilateral Implantation and Bilateral Implantation. Based on End Use, the market is segmented into Pediatrics and Adults. Based on Regions, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include MED-EL GmbH, Sonova Holding AG, William Demant Holding A/S, Starkey laboratories Inc., GN Store Nord A/S (GN Hearing A/S), Amplifon SpA (Ampliter N.V.), Widex A/S, Oticon Medical AB, Cochlear Ltd., Medtronic PLC.
By Fitting Type
By End Use
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
